Castleview Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $269K | Buy |
+501
| New | +$269K | 0.17% | 140 |
|
|
2024
Q2 | – | Sell |
-69
| Closed | -$37.3K | – | 962 |
|
|
2024
Q1 | $37.3K | Hold |
69
| – | – | 0.02% | 383 |
|
|
2023
Q4 | $38.3K | Hold |
69
| – | – | 0.03% | 356 |
|
|
2023
Q3 | $30.2K | Hold |
69
| – | – | 0.03% | 323 |
|
|
2023
Q2 | $34.7K | Hold |
69
| – | – | 0.03% | 307 |
|
|
2023
Q1 | $34.5K | Hold |
69
| – | – | 0.03% | 295 |
|
|
2022
Q4 | $28.1K | Hold |
69
| – | – | 0.03% | 277 |
|
|
2022
Q3 | $22K | Sell |
69
-1,063
| -94% | -$339K | 0.02% | 312 |
|
|
2022
Q2 | $206K | Buy |
1,132
+1,014
| +859% | +$185K | 0.16% | 136 |
|
|
2022
Q1 | $64K | Sell |
118
-77,580
| -100% | -$42.1M | 0.04% | 316 |
|
|
2021
Q4 | $118 | Buy |
+77,698
| New | +$118 | ﹤0.01% | 765 |
|
|
2021
Q2 | $75K | Buy |
+118
| New | +$75K | 0.03% | 338 |
|